In patients undergoing lung resection for non-small cell lung cancer, is lymph node dissection or sampling superior?

Interactive Cardiovascular and Thoracic Surgery

Volumn 13, Issue 3, 2011, Pages 311-315

  Hughes, Michael J ^a   Chowdhry, Mohammed F ^a   Woolley, Steve M ^a   Walker, William S ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Lymph node sampling; Lymphadenectomy; Non small cell lung cancer

Indexed keywords

ACCURACY; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; DISEASE FREE SURVIVAL; HUMAN; INTERMETHOD COMPARISON; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE SAMPLING; MEDIASTINAL LYMPH NODE DISSECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; SURVIVAL RATE;

BENCHMARKING; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PNEUMONECTOMY; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052599270     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2011.268979     Document Type: Article

References (16)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg 2003;2:405-409.
2. Wright G, Manser RL, Byrnes G, Hart D, Campbell DA. Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials. Thorax 2006;61:597-603.
3. Manser R, Wright G, Hart D, Byrnes G, Campbell DA. Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev 2005;1 CD004699.
4. Lim E, Baldwin D, Beckles M, Duffy J, Entwisle J, Faivre-Finn C, Kerr K, Macfie A, McGuigan J, Padley S, Popat S, Screaton N, Snee M, Waller D, Warburton C, Win T. Guidelines on the radical management of patients with lung cancer. Thorax 2010;65 (Suppl 3):iii1-iii27.
5. Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, Jones DR, McKenna RJ, Landreneau RJ, Rusch VJ, Putnam JB Jr. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg 2011;141:662-668.
6. Wu Y, Huang ZF, Wang SY, Yang XN, Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002;36:1-6.
7. Izbicki JR, Passlick B, Pantel K, Pichlmeier U, Hosch SB, Karg O, Thetter O. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg 1998;227:138-144.
8. Passlick B, Kubuschock B, Sienel W, Thetter O, Pantel K, Izbicki JR. Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases - results of a preliminary study. Eur J Cardiothorac Surg 2002;21:520-526.
9. Sugi K, Nawata K, Fujita N, Ueda K, Tanaka T, Matsuoka T, Kaneda Y, Esato K. Systematic lymph node dissection for clinically diagnosed peripheral non-small cell lung cancer less than 2 cm in diameter. World J Surg 1998;22:290-295.
10. Doddali C, Aragon A, Barlesi F, Chetaille B, Robitail S. Does the extent of lymph node dissection influence outcome in patients with stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2005;27:680-685.
11. Okada M, Sakamoto T, Yuki T, Mimura T, Miyoshi K, Tsubota N. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Thorac Surg 2006;81:1028-1032.
12. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 2003;21:1029-1034.
13. Zhang GQ, Han F, Gao SL, A DL, Pang ZL. Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases. Ai Zheng 2007;26:519-523.
14. Keller SM, Adak S, Wagner H, Johnson DH. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg 2000;70:358-365.
15. Izbicki JR, Passlick B, Karg O, Bloechle C, Pantel K, Knoefel WT, Thetter O. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg 1995;59:209-214.
16. Barnard J, Dunning J, Musleh G, Odom N. Is there a role for the use of radical lymph node dissection in the surgical management of resectable non-small cell lung cancer. Interact CardioVasc Thorac Surg 2003;3:294-299.